Biology and Clinical Use of Glucagon-Like Peptide-1 Receptor Agonists in Vascular Protection
{{output}}
Glucagon-like peptide-1 receptor agonists (GLP1RA) are incretin agents initially designed for the treatment of type 2 diabetes mellitus but because of pleiotropic actions are now used to reduce cardiovascular disease in people with type 2 diabetes mellitus and... ...
